Companies
JMP Securities slashes price target on Ambrx Biopharma Inc. [AMAM] – find out why.
Ambrx Biopharma Inc. [NASDAQ: AMAM] gained 0.83% on the last trading session, reaching $27.93 price per share at the time. The company report on January 8, 2024 at 7:35 AM that Ambrx Announces Sale to Johnson & Johnson. “We are excited to reach this agreement
